3 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow ABNCoV2 vaccine: new trials by email Literature Review of ABNCoV2 vaccine trials Research Report on ABNCoV2 vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 ABNCoV2, Comirnaty - COVID-19 Disease | Phase 3 | Completed | Bavarian Nordic | 4205 | 2022-08-30 | 2025-02-24 |
| ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects ABNCoV2 100ug, ABNCoV2 50ug - COVID-19 Disease | Phase 2 | Completed | Bavarian Nordic | 197 | 2021-08-19 | 2024-09-27 |
| Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) ABNCoV2 Vaccine - Covid19, Severe Acute Respiratory Syndrome | Phase 1 | Completed | Radboud University Medical Center | 45 | 2021-03-11 | 2026-02-17 |
COVID-19 (1) · Severe Acute Respiratory Syndrome (1)
Bavarian Nordic (2) · Radboud University Medical Center (1)
Belgium (1) · Denmark (1) · Germany (1) · Netherlands (1) · United States (1)
Christine Grigat, MD (1) · Leo James, MD (1)